We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Long-Standing Distribution Agreement Between Instrumentation Laboratory and Beckman Coulter Comes to an End

By LabMedica International staff writers
Posted on 07 Jun 2012
Print article
After over 20 years of successful collaboration, Instrumentation Laboratory (Bedford, MA, USA) announced that their Strategic Alliance Cross-Distribution agreement with Beckman Coulter, Inc. (Brea, CA, USA) over their Hemostasis product line will terminate June 22, 2012.

Instrumentation Laboratory, a worldwide developer, manufacturer, and distributor of in vitro diagnostic instruments, related reagents, and controls, will end their distribution partnership with Beckman Coulter, a provider of instrument systems and products for life science. Beginning June 23, 2012, Instrumentation Laboratory will initiate direct sale and support services in the USA and Canada for their own Hemostasis product line in order to improve the quality of their products and services and simplify lab operations.

A strong focus on quality is precisely what has led to Instrumentation Laboratory’s success among hospitals and independent clinical laboratories worldwide, explained Ramon Benet, CEO, Instrumentation Laboratory, who is optimistic about the transition.

“[Instrumentation Laboratory] has achieved significant growth in Hemostasis, culminating in the attainment of the number one market share position worldwide, thanks to our focus on quality and innovation,” said Mr. Benet. “Now is the ideal time for us to apply our expertise, resources, and world-class service organization to working directly with our Hemostasis customers in North America, and focus on ensuring a smooth transition for our customers.”

Instrumentation Laboratories is currently the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer in 1985, the ACL 810, the company has continuously introduced innovative hospital and specialty lab products, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems.

Along with Hemostasis systems, Instrumentation Laboratory’s product lines also include Critical Care and information management systems.



Related Links:

Instrumentation Laboratory

Beckman Coulter

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.